Watch Ticker

BioVie, Inc. Common Stock

Go to BioVie, Inc. Common Stock Website

$5.13

-0.87 (-14.54%)

Live

Previous Close

Day Range

$4.86 - $6.01

Previous Day Range

$5.75 - $6.15

Market Cap

$11.2 million USD

Day Vol.

151601

Previous Day Vol.

55390

Currency

USD

Primary Exchange

Nasdaq

BioVie Inc is a clinical-stage company developing drug therapies to treat chronic debilitating conditions including liver disease and neurological and neuro-degenerative disorders and certain cancers. The Company is conducting a potentially pivotal P...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Biovie Inc. - BioVie Presented Data Highlighting that Patients Treated with Bezisterim Potentially Experienced an Age Deceleration Advantage Compared to Placebo on 10 Different Biological Clocks at the 2nd World Conference on Aging and Gerontology

BioVie presented research showing its drug Bezisterim potentially reduces biological age in Alzheimer's patients by modulating DNA methylation across multiple biological clocks, with significant improvements in inflammatory and metabolic biomarkers.

Related tickers: BIVI.

Read Full Article

Delveinsight - Alzheimer’s Therapeutics Market on Upward Trajectory Across the 7MM During the Forecast Period (2025–2034) Fueled by Drug Development Advances | DelveInsight

The Alzheimer's disease market is expected to grow significantly between 2025-2034, driven by emerging therapies targeting disease mechanisms and improved diagnostic capabilities, with the US market representing approximately 50% of the total market size.

Related tickers: NVO, LLY, BIVI, ANVS.

Read Full Article

Trending Tickers

Please sign in to view